Human Autologous Rosettes. II. Prognostic Significance of Variations in Autologous Rosette-Forming Cells in the Peripheral Blood of Cancer Patients2
- 1 September 1979
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 63 (3) , 593-597
- https://doi.org/10.1093/jnci/63.3.593
Abstract
The distribution of autologous rosette-forming cells (A-RFC) was determined in 55 samples of peripheral blood mononuclear cells from healthy adult donors and 407 samples from 112 cancer patients. The mean percentage and absolute number of A-RFC were significantly reduced in the cancer patients compared to the healthy adult donors. These values for A-RFC were even more significantly reduced in patients with cancer relapse than in patients with complete remission of cancer. Thus diminution of this pertinent subset of T[thymus-derived]-lymphocytes has interesting clinical value by its being closely related to an adverse prognosis.This publication has 8 references indexed in Scilit:
- Human autologous rosettesCellular Immunology, 1979
- Quantitative comparison of K cell potential in human T and null cellsEuropean Journal of Immunology, 1978
- Relationship between T lymphocyte levels and lymphoproliferative responses to mitogens and alloantigens in lung and breast cancer patientsInternational Journal of Cancer, 1978
- Detection of decreased proportion of lymphocytes forming rosettes with sheep erythrocytes at 29°C in the blood of cancer patientsClinical Immunology and Immunopathology, 1977
- A simple and rapid method to distinguish between rosettes and non-specific aggregation of erythrocytes in the rosette assay for human T-lymphocytesJournal of Immunological Methods, 1977
- Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's diseaseCancer, 1976
- An examination of the immunology of cancer patientsInternational Journal of Cancer, 1976
- Cell-mediated immunity in patients with carcinoma.Correlation between clinical stage and immunocompetenceCancer, 1976